GlassScriptPhysician profile
Andrew Carlone
NPI 1083076459
$17,621.56
in general payments reported to CMS, 2019-2025
20 companies · $204 in 2025
The $204 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $101 · 2021: $1,261 · 2022: $7,504 · 2023: $7,596 · 2024: $587 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $6,000 · Travel and Lodging: $1,311 · Food and Beverage: $1,076.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $6,000.00 |
| Travel and Lodging | $1,311.45 |
| Food and Beverage | $1,075.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $13,748.64 | 2021-2025 | Djo Surgical |
| Stryker Corporation | $1,735.17 | 2019-2022 | |
| Osteoremedies, LLC | $369.24 | 2022 | |
| Linkbio Corp | $364.42 | 2022 | |
| Alpha Orthopedic Systems | $195.31 | 2022 | |
| Zimmer Biomet Holdings, INC. | $192.68 | 2019-2021 | |
| Smith+Nephew, INC. | $157.24 | 2021-2023 | Pico |
| Orthalign INC | $127.61 | 2022 | |
| Depuy Synthes Sales INC. | $125.00 | 2021 | |
| Medical Device Business Services, INC. | $114.13 | 2019 | |
| Kci USA, INC. | $99.71 | 2021-2023 | Prevena Restor Arthroform, Prevena, Prevena Restor Rotoform |
| Medtronic, INC. | $76.75 | 2023-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Inceptiv |
| Medacta USA, INC. | $59.00 | 2024 | |
| Abbvie INC. | $55.60 | 2023-2025 | Dalvance, Teflaro |
| Pacira Pharmaceuticals Incorporated | $50.09 | 2023-2025 | Zilretta, Iovera, Exparel |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $41.35 | 2023-2024 | Allograft Tissue, Hall Power |
| Bioventus LLC | $34.74 | 2025 | Durolane |
| Uoc USA INC | $28.72 | 2023 | U2 Psa and Ustar II |
| Molnlycke Health Care US, LLC | $25.84 | 2024 | Avance, Mepilex Border Post-Op Ag |
| Solventum Corporation | $20.32 | 2024 | Prevena, V.A.C. Veraflo, Bair Paws |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Carlone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.